Article
Urology & Nephrology
Hamed Ahmadi, Seyedeh Sanam Ladi-Seyedian, Badrinath Konety, Kamal Pohar, Jeffrey M. Holzbeierlein, Max Kates, Brian Willard, Jennifer M. Taylor, Joseph C. Liao, Hristos Z. Kaimakliotis, Sima P. Porten, Gary D. Steinberg, Mark D. Tyson, Yair Lotan, Siamak Daneshmand
Summary: Blue-light cystoscopy plays a significant role in detecting invasive lesions not visible on white-light cystoscopy, with a considerable rate of pathological upstaging observed.
Article
Urology & Nephrology
Irene J. Beijert, Anouk E. Hentschel, Johannes Bruendl, Eva M. Comperat, Karin Plass, Oscar Rodriguez, Jose D. Subiela Henriquez, Virginia Hernandez, Enrique de la Pena, Isabel Alemany, Diana Turturica, Francesca Pisano, Francesco Soria, Otakar Capoun, Lenka Bauerova, Michael Pesl, H. Maxim Bruins, Willemien Runneboom, Sonja Herdegen, Johannes Breyer, Antonin Brisuda, Ana Calatrava, Jose Rubio-Briones, Maximilian Seles, Sebastian Mannweiler, Judith Bosschieter, Venkata R. M. Kusuma, David Ashabere, Nicolai Huebner, Juliette Cotte, Roberto Contieri, Laura S. Mertens, Francesco Claps, Alexandra Masson-Lecomte, Fredrik Liedberg, Daniel Cohen, Luca Lunelli, Olivier Cussenot, Soha El Sheikh, Dimitrios Volanis, Jean-Francois Cote, Morgan Roupret, Andrea Haitel, Shahrokh F. Shariat, A. Hugh Mostafid, Jakko A. Nieuwenhuijzen, Richard Zigeuner, Jose L. Dominguez-Escrig, Jaromir Hacek, Alexandre R. Zlotta, Maximilian Burger, Matthias Evert, Christina A. van de Kaa, Antoine G. van der Heijden, Lambertus A. L. M. Kiemeney, Viktor Soukup, Luca Molinaro, Paolo Gontero, Carlos Llorente, Ferran Algaba, Joan Palou, James N'Dow, Maria J. Ribal, Theo H. van der Kwast, Marko Babjuk, Richard J. Sylvester, Bas W. G. van Rhijn
Summary: There were no significant differences in terms of recurrence, progression, or overall survival (OS) among patients undergoing restaging, second, or repeat transurethral resection of the bladder (re-TURB) for non-muscle invasive bladder cancer (NMIBC). However, patients who underwent repeat re-TURB had a shorter time to death due to bladder cancer compared to those who had second or restaging re-TURB, highlighting the importance of separately evaluating different indications for re-TURB.
INTERNATIONAL UROLOGY AND NEPHROLOGY
(2023)
Review
Medicine, General & Internal
Lillian Y. Lai, Sean M. Tafuri, Emily C. Ginier, Lindsey A. Herrel, Philipp Dahm, Philipp Maisch, Giulia Ippolito Lane
Summary: Narrow band imaging (NBI)-guided transurethral resection of bladder tumor (TURBT) can reduce the risk of disease recurrence in non-muscle invasive bladder cancer, with little impact on the risks of major or minor adverse events.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
(2022)
Review
Surgery
Zhinan Fan, Hongjin Shi, Jiayu Luo, Xinquan Guo, Bo Wang, Yao Liu, Junjie Yu
Summary: Fluorescence cystoscopy and narrow-band imaging (NBI) are advantageous for treating and diagnosing patients with nonmuscle-invasive bladder cancer.
INTERNATIONAL JOURNAL OF SURGERY
(2023)
Article
Oncology
Ye-Ling Liu, Xue-Lin Wang, Xiao-Hui Yang, Xiao-Huan Wu, Guo-Xin He, Li-Min Xie, Xun-Jie Cao, Xu-Guang Guo
Summary: Xpert Bladder Cancer demonstrates high accuracy and specificity in diagnosing bladder cancer compared to cystoscopy. Further research is needed to confirm these findings.
WORLD JOURNAL OF SURGICAL ONCOLOGY
(2021)
Article
Oncology
Hao Liang, Qingya Yang, Yaozhong Zhang, Hui Sun, Qiang Fu, Tongxiang Diao, Jin Wang, Wei Huang, Yang Xu, Nan Ge, Xuewen Jiang, Shouzhen Chen, Yan Li, Bin Zhou, Peixin Li, Xiaoyi Zhang, Nianzhao Zhang, Benkang Shi, Jun Chen
Summary: The purpose of the study is to establish a reliable model for predicting the nature of bladder tumors. Factors related to tumor pathology were identified through the collection and analysis of clinical data and a diagnostic prediction model was established. The internal and external validation results showed that the model has good prediction performance.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Urology & Nephrology
Matthew Zibelman, Aeen M. Asghar, Daniel C. Parker, John O'Neill, Shuanzeng Wei, Richard E. Greenberg, Marc C. Smaldone, David Y. T. Chen, Rosalia Viterbo, Robert G. Uzzo, Evan Bloom, Rutika Kokate, Daniel M. Geynisman, Pooja Ghatalia, Mengying Deng, Eric A. Ross, Elizabeth Plimack, Philip H. Abbosh, Alexander Kutikov
Summary: This study aimed to evaluate the reliability and limitations of cystoscopic evaluation in candidates for radical cystectomy, showing that systematic endoscopic evaluation was unable to accurately predict post-operative pathology results. Further research is needed to explore novel imaging and biomarker strategies to optimize decision making regarding bladder preservation.
JOURNAL OF UROLOGY
(2021)
Article
Multidisciplinary Sciences
Johannes Breyer, Markus Eckstein, Danijel Sikic, Felix Wezel, Florian Roghmann, Mirco Brehmer, Ralph M. Wirtz, Jonas Jarczyk, Philipp Erben, Veronika Bahlinger, Franziska Goldschmidt, Guido Fechner, Jack Chen, Ellen Paxinos, Michael Bates, Maximilian Haas, Friedemann Zengerling, Christian Bolenz, Maximilian Burger, Arndt Hartmann, Maximilian C. Kriegmair
Summary: This study aimed to compare the accuracy of Xpert bladder cancer monitor with clinical assessment in predicting the need for 2nd TURB. The results showed that clinical assessment outperformed Xpert monitor. Xpert monitor may be an option to omit 2nd TURB for patients with pTa disease.
SCIENTIFIC REPORTS
(2023)
Review
Urology & Nephrology
Paul Gravestock, Nicholas Coulthard, Rajan Veeratterapillay, Rakesh Heer
Summary: This study conducted a meta-analysis on the effect of narrow band imaging-guided transurethral resection of bladder tumor compared with white light on recurrence rates in non-muscle-invasive bladder cancer. The analysis did not show a statistically significant benefit to narrow band imaging at 12 months, although a trend in its favor was identified. Further well-designed trials are required to examine the benefit of this technology, considering limitations such as varied reporting and administration of adjuvant therapies.
INTERNATIONAL JOURNAL OF UROLOGY
(2021)
Article
Medicine, General & Internal
Hao Liang, Qingya Yang, Hui Sun, Yang Xu, Jin Wang, Wei Huang, Nan Ge, Qiang Fu, Tongxiang Diao, Xuewen Jiang, Shouzhen Chen, Yan Li, Nianzhao Zhang, Benkang Shi, Jun Chen
Summary: This study aims to investigate the correlation between the morphological characteristics of tumor vessels and the nature, stage, and grade of bladder cancer, and found that different morphological features of tumor vessels are closely associated with the development and prognosis of bladder cancer.
ANNALS OF MEDICINE
(2023)
Article
Urology & Nephrology
Abhishek Bhat, Deukwoo Kwon, Nachiketh Soodana-Prakash, Ali Mouzannar, Sanoj Punnen, Mark L. Gonzalgo, Dipen J. Parekh, Chad R. Ritch
Summary: The study aimed to determine the optimal cystoscopic interval for intermediate risk, nonmuscle invasive bladder cancer. Results showed that moderate intensity (6-month) surveillance intervals in this patient population allow for timely detection without compromising oncological outcomes, and are less costly with fewer cystoscopies compared to high intensity (3-month) intervals.
JOURNAL OF UROLOGY
(2021)
Article
Urology & Nephrology
Taylor Parisse, Katy Reines, Ramsankar Basak, Dana Mueller, Randall Teal, Maihan B. Vu, Jessica Carda-Auten, Kathryn Stein, Kara Giannone, Robert Lipman, Angela B. Smith
Summary: This study aimed to explore the perspectives of patients and providers on repeat transurethral resection of bladder tumors, in order to improve counseling and treatment options for nonmuscle-invasive bladder cancer. The findings showed differences in treatment preferences and emphasized the need for better communication and counseling in this area.
JOURNAL OF UROLOGY
(2023)
Review
Biotechnology & Applied Microbiology
Alison Schulz, Justin Loloi, Luis Pina Martina, Alexander Sankin
Summary: Bladder cancer is a challenging disease with high recurrence rates, leading to invasive surveillance methods. Non-invasive urinary tests have gained attention for early detection and to reduce unnecessary procedures; however, there is a need for improved sensitivity and specificity. Recent advancements in technology and research offer novel detection systems and biomarkers that show promise in clinical practice.
ONCOTARGETS AND THERAPY
(2022)
Article
Urology & Nephrology
Arighno Das, Jason E. Cohen, Oliver S. Ko, Brian J. Jordan, Alexander P. Glaser, Gregory B. Auffenberg, Joshua J. Meeks
Summary: The creation and distribution of individual surgeon scorecards improved detrusor muscle sampling during transurethral resection, leading to a decreased risk of disease recurrence in patients with nonmuscle invasive bladder cancer.
JOURNAL OF UROLOGY
(2021)
Review
Oncology
Giorgio I. Russo, Tamir N. Sholklapper, Andrea Cocci, Giuseppe Broggi, Rosario Caltabiano, Angela B. Smith, Yair Lotan, Giuseppe Morgia, Ashish M. Kamat, J. Alfred Witjes, Siamak Daneshmand, Mihir M. Desai, Indebir S. Gill, Giovanni E. Cacciamani
Summary: Bladder cancer, especially non-muscle invasive bladder cancer (NMIBC), remains a prevalent malignancy with high recurrence and progression rates despite early detection and surveillance. Studies comparing photodynamic diagnosis (PDD), narrow band imaging (NBI), and conventional white light cystoscopy (WLC) showed that tumor resection with PDD and NBI had higher diagnostic sensitivity for NMIBC compared to WLC alone. Integrating these enhanced technologies into standard care for suspected or confirmed NMIBC patients is recommended based on the findings.